Pasar al contenido principal

SINUCLEINOPATIAS Y OLIGONUCLEOTIDOS INHIBITORIOS: ROL DE ALFA Y GAMA SINUCLEINAS EN LA REGULACION DE LA FUNCION COGNITIVA

SAF2016-75797-R

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Convocatoria Proyectos I+D+i Retos de Investigación
Año convocatoria 2016
Plan Estatal 2013-2016 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario CONSORCI INSTITUT D INVESTIGACIONS BIOMEDIQUES AUGUST PI I SUNYER

Resultados relacionados

Resultados totales (Incluyendo duplicados): 4
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Contribución de congreso (ConferenceOutput)

Murine model of depression: astroglial glutamate transporter knockdown in infralimbic cortex induces a depressive phenotype

  • Fullana, Neus
  • Ruiz-Bronchal, Esther
  • Ferrés-Coy, Albert
  • Bortolozzi, Analía
  • Artigas, Francesc
Trabajo presentado en el Neuroscience 2017, celebrado en Washington del 11 al 15 de noviembre de 2017, Emerging evidence suggests that dysregulations of glutamatergic neurotransmission in prefrontal cortex are involved in the pathophysiology of depression. Astrocytes regulate excitatory neurotransmission by removing synaptic glutamate via GLAST and GLT-1 transporters. We demonstrated that unilateral knockdown of GLAST and GLT-1 in mouse infralimbic (IL) cortex induced by the local micro-infusion of small interfering RNAs (siRNA) targeting either transporter evoked a depressive-like phenotype. Conversely, intra-prelimbic (Prl) cortex microinfusion of both siRNAs did not affect behavioral responses despite comparable reductions of GLAST and GLT-1-1 expression in both PFC subdivisions. Downregulation of GLAST and GLT-1 remained diminished for at least 3 day and recovered 7 days post-administration. The depressive-like phenotype induced by reducing GLT-1 and GLAST expression in IL may be due to a hypoactive serotonergic (5-HT) system since it was reversed by the antidepressant drug citalopram. Likewise, microdialysis experiments revealed that siRNA-treated mice exhibited a reduced basal 5-HT release in the dorsal raphe nucleus (DRN) compared with controls, and a similar effect of veratridine in both experimental groups, indicating a similar intracellular 5-HT content. Further, local infusion of the GABAA receptor antagonist bicuculline increased DRN-5-HT release more markedly in siRNA-treated mice, suggesting a greater inhibition of 5-HT neurons via GABAA receptors. However, local downregulation of both transporters in PrL did not alter baseline 5-HT in DRN not the effect of bicuculline on 5-HT release. Taken together, these observations suggest that 1) an alteration of astroglial glutamate uptake in ventral PFC regions (IL) evokes downstream changes in 5-HT function, associated to a depressive-like phenotype in mice, and 2) the regional specificity of the effect suggests a differential functional connectivity between PrL/IL and DRN 5-HT neurons. In addition, this potential new model of MDD shows several physio pathological markers observed in patients: reduced expression of GFAP, a smaller number of astrocytes in mPFC, as well as a decreased BDNF expression in mPFC and the hippocampal formation, which is highly and significantly correlated with the degree of glutamate transporter knockdown in IL, indicating a direct relationship between both processes. Overall, these findings improve our understanding of the pathophysiology of depression and could help to identify novel targets in antidepressant drug development, since this potential new MDD model mimics many of the functional and molecular alterations observed in MDD patients., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Contribución de congreso (ConferenceOutput)

Short -and long- term memory impairment in mice overexpressing alpha -and gamma- synuclein in the dopamine neurons. Implication in Parkinson' disease

  • Pavia-Collado, Rubén
  • Alarcón-Arís, Diana
  • Ruiz-Bronchal, Esther
  • Artigas, Francesc
  • Bortolozzi, Analía
Trabajo presentado en el Neuroscience 2017, celebrado en Washington del 11 al 15 de noviembre de 2017, Idiopathic Parkinson’s disease (PD) is characterized by progressive brain pathology affecting multiple neurotransmitter systems, leading to a diverse profile of autonomic, motor, cognitive and psychiatric dysfunctions. Multiple convergent lines of evidence implicate the aggregation and accumulation of α-synuclein in the PD pathogenesis. Moreover, post-translational changes of γ-synuclein increase the α-synuclein aggregation. α- and γ-Synuclein are members of the synuclein family of small cytoplasmatic neuron-specific proteins, and have been suggested to modulate the function of monoamine transporters (DAT, SERT). We previously reported that α-synuclein knockdown mice showed increased extracellular DA and 5-HT levels- compard to control mice- in caudate-putamen (CPu) and medial prefrontal cortex (mPFC) after DAT or SERT blockade with nomifensine or citalopram, respectively (Alarcón-Arís et al., in review). Given the role of monoamine neurotransmission in cognitive processes, in the present study we assessed the effects of over-expressing α- and γ-synuclein in DA neurons on short- and long-term spatial memory. We generated a mouse model overexpressing the human wild-type α- or γ-synuclein in DA neurons from the substantia nigra compacta (SNc) and ventral tegmental area (VTA) using an adeno-associated virus type-5 (AAV5)-α-synuclein or AAV10-γ-synuclein, unilaterally injected in SNc/VTA. AAV5-α-synuclein mice showed increased human α-synuclein mRNA levels in the ipsilateral SN over time, reaching a 278% of sham mice at 8 weeks post-infection. Similarly, AAV10-γ-synuclein mice reached to a maximal of 250% of sham mice. Overexpression of α- or γ-synuclein led to lower extracellular DA levels in CPu and mPFC compared to sham mice after local veratridine (50μM) or nomifensine (1-10-50μM) administration at 4-week post-infection. Moreover, overexpression of α- or γ-synuclein led to the impairment of working memory in mice, as revealed by passive avoidance and novel object recognition tests at 4-8 weeks post-infusion. Likewise, these mice showed deficits in the spatial learning using the Morris water maze. These non-motor symptoms appeared earlier than motor deficits assessed by the cylinder test and rotarod. Overall, these findings indicate that that 1) α- and γ-synuclein are directly involved in the regulation of cognitive functions, likely through changes in monoamine function, and 2) overexpression of α- or γ-synuclein in DA neurons mimics the temporal progression of clinical symptoms in PD, with early cognitive deficits appearing before motor symptoms., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Contribución de congreso (ConferenceOutput)

Antidepressant actions of ketamine engage cellular mechanisms of endoplasmic reticulum stress by the eIF2¿ pathway

  • Miquel-Rio, Lluís
  • Sarries-Serrano, Unai
  • Paz, Verónica
  • Campa, Leticia
  • Bortolozzi, Analía
Trabajo presentado en el 19th National Meeting of the Spanish Society of Neuroscience, celebrado en Lleida (España), del 3 al 5 de noviembre de 2021, Chaperone proteins and folding enzymes in endoplasmic reticulum (ER) perform a key role in proteostasis, which can be disrupted by numerous factors leading to an accumulation of unfolded proteins in the lumen. It results in ER stress and unfolded protein response (UPR) is elicited to restore homeostasis. However, under prolonged cellular stress, the UPR pathway can lead to cell dysfunction/loss. Impaired ER mechanisms are responsible for neurodegeneration in numerous human diseases and there is also growing evidence that ER stress is implicated in the neuronal dysfunctions of neuropsychiatric disorders. The present study was aimed to check the hypothesis that ER stress and UPR pathway over-activation in the serotonin (5-HT) neurons are involved in the cellular pathological mechanisms of anxiety and depression by causing an impaired proteasome function. ER stress was induced by a single local application of tunicamycin (200 μg/μl) in dorsal raphe nucleus of mice. We examined tunicamycin effects on proteins related to ER stress, UPR, and apoptosis, on serotonin function as well as on anxiety- and depression-like behaviors. Tunicamycin rapidly induced ER stress in 5-HT neurons, leading to a time-dependent increase in GRP78 protein levels. Furthermore, CHOP protein, which triggers apoptosis pathways, was also increased 7 days after tunicamycin infusion. ER stress led to an increased eIF2α and eEF2 phosphorylation, suggesting the activation of PERK pathway in 5-HT neurons. Tunicamycin-treated mice exhibited an anxious-depressive phenotype and showed altered 5-HT neurotransmission in medial prefrontal cortex. A single dose of ketamine (10 mg/kg, ip) reversed the depressive phenotype 30 minutes post-administration, which is linked to reduced levels of phosphorylated eIF2α and recovery of proteostasis. The results strongly indicate that ER stress and UPR may represent cellular pathogenic mechanisms in the development of mood disorders and the eIF2α pathway is central for antidepressant activity of ketamine., SAF2016-75797-R, PID2019-105136RB-100 (MINECO-ERDF), Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Contribución de congreso (ConferenceOutput)

Human α-synuclein overexpression in mouse serotonin neurons elicits a depressive phenotype: Focus on brain connectivity and synaptic density

  • Torres-López, María
  • Miquel-Rio, Lluís
  • Paz, Verónica
  • Casal, Carme
  • Muñoz-Moreno, Emma
  • López-Gil, Xavier
  • Bortolozzi, Analía
Resumen del trabajo presentado en el 19th National Meeting of the Spanish Society of Neuroscience, celebrado en Lleida (España), del 3 al 5 de noviembre de 2021, Anxiety and depression are the most prevalent neuropsychiatric disorders in Parkinson’s disease (PD) population (50%), often preceding the appearance of motor symptoms. Neuropathological and neurochemical changes in the serotonin (5-HT) system occurs during PD prodromal phase and contributes to a variety of non-motor symptoms. However, anxiety/depression brain circuits in PD are not known in detail. In this study, we hypothesized that synaptic impairments occur in the early stages of the disease onset before the neuronal cell loss. Dysregulating the synaptic junction would block neurotransmitter release, thus triggering a retrograde neurodegenerative process ending with neuronal cell loss by proceeding through the axons. We aimed to study whether synaptic density and functional connections are affected by α-synuclein accumulation in efferent brain regions from 5-HT raphe nuclei in the early stages of a depression/PD-like mouse model. We overexpressed human wild-type or A53T mutant α-synuclein (WTα-Syn and A53Tα-Syn, respectively) in 5-HT neurons using AAV vectors and two different synaptic markers, microtubule-associated protein 2 (MAP-2) and synaptic vesicle glycoprotein 2A (SV2A) were examined 4 and 8 weeks later. Mice overexpressing WTα-Syn showed progressive reductions of MAP-2 levels in different 5-HT-inervated cortices (e.g. prelimbic, infralimbic, cingulate and motor cortices), caudate putamen and different sub-fields of hippocampus. In parallel, WTα-Syn mice showed also an accumulation of SV2A protein in cingulate and motor cortices, and caudate-putamen. In addition, changes of MAP-2 and SV2A synaptic markers were also found in different 5-HT projection brain areas of A53Tα-Syn mice, although these changes were of greater magnitude. Brain functional activity was examined in these mice using rsfRMI and early gene zif628 expression. Altogether, these data suggest that changes in the density of MAP-2 and SV2A synaptic markers linked to α-synuclein-induced axonal pathology lead to reduced 5-HT neurotransmission evoking a depressive-phenotype, and these effects precede neuronal degeneration., SAF2016-75797-R, PID2019-105136RB-100 (MINECO-ERDF), Peer reviewed